ALVO - Alvotech


4.01
-0.150   -3.741%

Share volume: 311,842
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.17%

PREVIOUS CLOSE
CHG
CHG%

$4.16
-0.15
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
5.53%
1 Month
-21.98%
3 Months
-26.42%
6 Months
-50.86%
1 Year
-62.52%
2 Year
-74.29%
Key data
Stock price
$4.01
P/E Ratio 
0.00
DAY RANGE
$3.98 - $4.11
EPS 
N/A
52 WEEK RANGE
$3.65 - $11.85
52 WEEK CHANGE
-$62.52
MARKET CAP 
2.854 B
YIELD 
N/A
SHARES OUTSTANDING 
301.482 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-14-2025
BETA 
0.54
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$704,997
AVERAGE 30 VOLUME 
$652,179
Company detail
CEO: Mark L. PhD
Region: US
Website: alvotech.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

N/A

Recent news